Company NattoPharma ASA

NATTO

NO0010289200

Managers

Members of the board

Share class

Company contact information

Sector

Sector Other Pharmaceuticals

Inactive Instrument

Nattopharma ASA is a Norway-based biotechnology company, which sells and develops products containing natural vitamin K2. The Company markets its products under its own trademark MenaQ7, principally in Europe and North America. MenaQ7 is provided either as powder or as an oil solution, and is used in stand-alone form, in complex dietary products and as additives to functional products. Nattopharma ASA offers contract manufacturing of dietary products, biochemical tests, marketing and sales support services. It provides its products primarily to the healthcare, supplement and functional food markets. The Company has an alliance with VitaK BV, at the Cardiovascular Research Institute (CARIM) at the University of Maastricht in the Netherlands.

Number of employees: 18

Managers	Title	Age	Since
Kjetil Ramsøy CEO	Chief Executive Officer	52	15-12-31
Robert Schrama DFI	Director of Finance/CFO	-	20-03-08
Gunilla Traberg PRN	Corporate Officer/Principal	-	-
William Sommer LAW	General Counsel	-	14-12-31
Randall Eric Anderson SAM	Sales & Marketing	70	13-03-31

Members of the board	Title	Age	Since
Annette Elmqvist BRD	Director/Board Member	75	-
Frode Marc Bohan FOU	Founder	56	04-11-03
Katarzyna Zdzislaw Maresz BRD	Director/Board Member	50	11-01-31
Kjetil Ramsøy CEO	Chief Executive Officer	52	15-12-31
Sjur Thorsheim BRD	Director/Board Member	66	-
Stefan Halldén BRD	Director/Board Member	59	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	19,843,433	5,252,630 ( 26.47 %)	7,143 ( 0.0360 %)	26.47 %

NattoPharma ASA

Lilleakerveien 2B

0283, Oslo

+47 40 00 90 08

http://www.nattopharma.com/

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+25.95%	672B
NOVO NORDISK A/S	+25.87%	570B
JOHNSON & JOHNSON	-5.36%	360B
MERCK & CO., INC.	+16.57%	321B
ABBVIE INC.	+8.44%	300B
ASTRAZENECA PLC	+7.09%	217B
ROCHE HOLDING AG	-9.12%	204B
NOVARTIS AG	+5.01%	199B
PFIZER, INC.	-8.81%	149B

Other Pharmaceuticals